Article in Genes & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Alessa R RingelResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Natalia BenettiResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.ORCID 0000-0001-8202-9904
Andreas MaggResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.ORCID 0000-0003-4032-0175
Fabian GrollMedical Research Council Laboratory of Medical Sciences (MRC LMS), London W12 0HS, United Kingdom.ORCID 0000-0002-0991-0233
Robert SchöpflinResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Mira KühnleinResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Asita Carola StiegeResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Ute FischerResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Lars WittlerDepartment of Developmental Genetics, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.ORCID 0000-0001-7873-6702
Laurence GameMedical Research Council Laboratory of Medical Sciences (MRC LMS), London W12 0HS, United Kingdom.
Stephan LorenzSequencing Core Facility, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.ORCID 0000-0002-6678-355X
George YoungMedical Research Council Laboratory of Medical Sciences (MRC LMS), London W12 0HS, United Kingdom.ORCID 0000-0002-1203-588X
Stefan MundlosResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany; l.allou@lms.mrc.ac.uk mundlos@molgen.mpg.de.ORCID 0000-0002-9788-3166
Lila AllouResearch Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany; l.allou@lms.mrc.ac.uk mundlos@molgen.mpg.de.ORCID 0000-0001-7824-1945
Funding
Medical Research Council MC-A652-5QA34
6 · The paper itself
Abstract
The precise spatiotemporal regulation of developmental genes is required for proper organogenesis.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.